Prescription Lens Global Market Report 2024

The prescription lens market size has grown strongly in recent years. It will grow from $43.46 billion in 2023 to $46.09 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to the rise of computers and smartphones leading to greater awareness and demand for lenses, increased awareness and diagnosis of vision problems, the emergence of online retailers and direct-to-consumer brands and the rise of fashion and designer eyewear.

The prescription lens market size is expected to see strong growth in the next few years. It will grow to $58.62 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth during the forecast period is linked to heightened public awareness and education concerning eye health, the expansion of online retail platforms, economic factors and disposable income levels, the extent of insurance coverage for vision care and eyewear, rising urbanization, and prolonged utilization of digital screens. Key trends expected in this period involve the integration of augmented reality (AR) and virtual reality (VR), growing demand for lenses that filter blue light from screens, advancements in photochromic lenses, enhanced anti-fog technologies, the utilization of digital eye strain diagnostics, and 3D printing.

The rising occurrence of vision impairment is anticipated to drive the expansion of the prescription lens market in the future. Vision impairment encompasses a range of eye conditions, spanning from common issues such as partial vision loss and blindness to more severe ailments such as macular degeneration. The surge in vision impairment cases is attributed to increased screen time, digital device usage, and aging demographics, contributing to conditions such as digital eye strain, myopia, and age-related macular degeneration. Prescription lenses assist in rectifying vision impairments such as myopia, hyperopia, astigmatism, and presbyopia by refracting light to focus properly on the retina, thereby enhancing vision clarity and reducing strain. For instance, in May 2023, a report published by the National Center for Biotechnology Information, an international resource for scientific research based in the US, indicated that approximately 200 million individuals worldwide suffered from age-related macular degeneration (AMD) in 2020. Projections suggest that by 2040, the number of affected individuals will increase to around 288 million. Hence, the increasing prevalence of vision impairment is propelling the growth of the prescription lens market.

Prominent companies in the prescription lens market are creating myopia management spectacle lenses to meet the increasing demand for efficient myopia control among children. These specialized glasses are crafted to decelerate the progression of myopia (nearsightedness) in children and adolescents. For example, in November 2023, Shamir Optical Industry, an Israel-based manufacturer of optical lenses for eyeglasses, introduced Shamir Optimee, a novel myopia management spectacle lens tailored to address the growing necessity for effective myopia control, particularly in children. This innovative lens incorporates Shamir Focusflow's state-of-the-art defocus technology, featuring a clear central vertical zone aligned with the child's prescription, thereby facilitating flexible eye movement during near-vision activities.

In December 2022, Meta Platforms Inc., a US-based information technology company, purchased Luxexcel for an undisclosed sum. Through this acquisition, Meta seeks to incorporate Luxexcel's advanced 3D printing technology for prescription lenses into Meta's augmented reality (AR) and virtual reality (VR) products, thereby improving the creation of AR or VR wearables with tailored lenses to enhance user experiences. Luxexcel, headquartered in the Netherlands, specializes in the development of 3D-printed prescription lenses for smart glasses.

Major companies operating in the prescription lens market are Johnson And Johnson Inc., EssilorLuxottica S.A., Carl Zeiss AG, Seiko Optical Products Co. Ltd., Alcon, Hoya Corporation, Nikon Corporation, Bausch And Lomb Incorporated, The Cooper Companies, Safilo Group S.p.A, Marchon Eyewear Inc., Rodenstock GmbH, Menicon Co. Ltd., Warby Parker Inc., Norville Group Ltd, De Rigo Vision S.p.A., ABB Optical Group, Walman Optical, Oakley Inc., Younger Optics, Maui Jim Inc., Charmant Group Inc., Thom Browne Eyewear LLC, Vision Ease Corporation, Zenni Optical LLC.

North America was the largest region in the prescription lens market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription lens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the prescription lens market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A prescription lens is a personalized optical lens crafted to address particular vision issues according to an individual's eye prescription. These lenses are utilized to rectify vision impairments linked to particular medical conditions or eye injuries.

The primary varieties of prescription lenses encompass single-vision, bifocal, trifocal, progressive, active, and others. Single vision constitutes a fundamental prescription lens typically covered by government healthcare initiatives for individuals necessitating correction for a single vision impairment, such as nearsightedness or farsightedness. It incorporates diverse coatings such as anti-reflective, scratch-resistant coating, anti-fog coating, and ultraviolet treatments, which cater to various needs including myopia, hyperopia or hypermetropia, astigmatism, and presbyopia.

The prescription lens market research report is one of a series of new reports that provides prescription lens market statistics, including prescription lens industry global market size, regional shares, competitors with a prescription lens market share, detailed prescription lens market segments, market trends, and opportunities, and any further data you may need to thrive in the prescription lens industry. This prescription lens market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prescription lens market consists of sales of products such as trivex lenses, UV (ultraviolet) protection lenses, aspheric lenses, blue light-blocking lenses and polycarbonate lenses. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.